亚太泻药市场 – 行业趋势及 2030 年预测

亚太泻药市场分析及规模

亚太地区泻药市场经历了显著增长，因为人口老龄化加剧带来的沉重负担是推动市场需求的主要驱动因素。泻药产品安全性高，以及对使用天然、合成和可生物降解材料生产泻药的重视程度不断提高，是预测期内推动市场需求的主要驱动因素。                          

Data Bridge Market Research 分析称，2022 年亚太地区泻药市场规模为 69.1412 亿美元，预计到 2030 年将达到 120.3412 亿美元，预计在 2023 年至 2030 年的预测期内复合年增长率为 7.0%。由于生活方式和饮食习惯的改变，“渗透性泻药”在亚太地区泻药市场类型细分中占据主导地位。除了市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

亚太泻药市场范围和细分

市场定义

泻药是增加/刺激排便或软化粪便的药剂。它们有助于加速肠道运输，从而加快消化道的运动以刺激排便。它用于治疗便秘，便秘是一种以排便困难、不频繁和有时疼痛为特征的疾病。泻药可在柜台 (OTC) 购买。泻药主要有四种类型：渗透性泻药、刺激性泻药、容积性泻药、润滑剂和润肤性泻药。

亚太泻药市场动态

驱动程序

• 改变生活方式和饮食习惯

过去几十年来，亚太地区的生活方式和饮食习惯发生了重大变化。随着城市化进程加快和久坐生活方式的普及，胃肠道问题（尤其是便秘）明显增多。这种变化可归因于体力活动减少、纤维摄入不足以及对加工食品和方便食品的偏好日益增加。这些饮食和生活方式的变化导致便秘发病率上升，推动了该地区对泻药产品的需求。

• 提高医疗保健意识

The Asia-Pacific region has seen a notable increase in healthcare awareness and accessibility. This rise in awareness has led to greater recognition and diagnosis of gastrointestinal disorders, including constipation. Patients are now more likely to seek medical advice and opt for pharmaceutical solutions, contributing to the expanding market for laxatives.

• Consumer Preference for OTC Laxatives

Over-the-counter (OTC) laxatives have gained popularity in the Asia-Pacific region due to their convenience and accessibility. Consumers appreciate the ease of purchasing these products without the need for a prescription. Moreover, OTC laxatives are often considered a first-line treatment for mild and occasional constipation. This consumer preference for readily available OTC laxatives has further fueled the growth of the laxative market.

Opportunities

• Rising Health and Wellness Trends

The increasing focus on health and wellness among consumers presents a notable opportunity for laxative manufacturers. Beyond merely providing relief from constipation, manufacturers can position their products as contributors to overall digestive health. This approach aligns with the growing trend of consumers seeking products that promote holistic well-being, creating a potential avenue for market growth.

• Product Innovation in Laxative Formulation

Continuous innovation in laxative formulations offers significant opportunities for market expansion. Manufacturers can invest in research and development to develop gentler and more natural laxatives with fewer side effects. Innovations that enhance tolerability and reduce discomfort associated with laxative use can resonate with consumers seeking effective yet gentle solutions for constipation relief.

Restraints/Challenges

• Stringent Regulatory Oversight

Regulatory bodies in the Asia-Pacific region impose strict regulations on the sale and distribution of pharmaceutical products, including laxatives. These regulations are in place to ensure consumer safety and product efficacy. Manufacturers must adhere to stringent standards and undergo rigorous testing and approvals processes. Compliance with regulatory requirements can lead to increased operational costs and limitations on marketing activities, posing a significant restraint in the market.

• Cultural and Dietary Variations across the Asia-Pacific

Cultural and dietary variations across the Asia-Pacific region require a nuanced and culturally sensitive approach to marketing laxatives. Manufacturers must consider local preferences, traditional remedies, and healthcare practices when promoting their products. Failure to navigate these cultural factors effectively can impact market acceptance and success.

This Asia-Pacific laxative market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific laxative market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In October 2021, Abbott had launched the Duphalac laxative in India. Duphalac Bears in strawberry flavor is a laxative cum food supplement and has met with the FSSAI regulations. It delivers the advantages of a trusted prebiotic and motivates the growth of good bacteria in the digestive system. The product launch would pave an important step in the children’s health improvement. It will result in increased net sales and more product range

Asia-Pacific Laxative Market Analysis and Size

Asia-Pacific laxative market has experienced significant growth due to the high burden of an increase in aging population are the major drivers which propelled the demand of the market. High level safety associated with laxative products and rising emphasis on production of laxatives from natural, synthetic and biodegradable materials are the major drivers which propelled the demand of the market in the forecast period.             

Data Bridge Market Research analyses that the Asia-Pacific laxative market which was USD 6,914.12 million in 2022, is expected to reach USD 12,034.12 million by 2030, and is expected to undergo a CAGR of 7.0% during the forecast period of 2023 to 2030. “Osmotic Laxatives” dominates the type segment of the Asia-Pacific laxative market due to changing lifestyle and dietary. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Asia-Pacific Laxative Market Scope and Segmentation

Market Definition

Laxative are the agents which either increase/stimulate bowel movement or loosen stools. They help in accelerate intestinal transit, which speed up the movement of digestive tract to stimulate bowel movement. Itis used for treating constipation, a condition characterized by difficult, infrequent and sometime painful bowel movement. The laxatives are available as Over the Counter (OTC). The four main types of laxative are osmotic laxative, a stimulant laxative, bulk laxative, lubricant, and emollient laxative.

Asia-Pacific Laxative Market Dynamics

Drivers

• Changing Lifestyle and Dietary Habits

The Asia-Pacific region has witnessed a significant shift in lifestyle and dietary habits over the past few decades. As urbanization has accelerated and sedentary lifestyles have become more prevalent, there has been a noticeable increase in gastrointestinal issues, particularly constipation. This shift can be attributed to reduced physical activity, inadequate fiber intake, and a growing preference for processed and convenience foods. These dietary and lifestyle changes have led to a rising incidence of constipation, driving the demand for laxative products in the region.

• Increased Healthcare Awareness

The Asia-Pacific region has seen a notable increase in healthcare awareness and accessibility. This rise in awareness has led to greater recognition and diagnosis of gastrointestinal disorders, including constipation. Patients are now more likely to seek medical advice and opt for pharmaceutical solutions, contributing to the expanding market for laxatives.

• Consumer Preference for OTC Laxatives

Over-the-counter (OTC) laxatives have gained popularity in the Asia-Pacific region due to their convenience and accessibility. Consumers appreciate the ease of purchasing these products without the need for a prescription. Moreover, OTC laxatives are often considered a first-line treatment for mild and occasional constipation. This consumer preference for readily available OTC laxatives has further fueled the growth of the laxative market.

Opportunities

• Rising Health and Wellness Trends

The increasing focus on health and wellness among consumers presents a notable opportunity for laxative manufacturers. Beyond merely providing relief from constipation, manufacturers can position their products as contributors to overall digestive health. This approach aligns with the growing trend of consumers seeking products that promote holistic well-being, creating a potential avenue for market growth.

• Product Innovation in Laxative Formulation

Continuous innovation in laxative formulations offers significant opportunities for market expansion. Manufacturers can invest in research and development to develop gentler and more natural laxatives with fewer side effects. Innovations that enhance tolerability and reduce discomfort associated with laxative use can resonate with consumers seeking effective yet gentle solutions for constipation relief.

Restraints/Challenges

• Stringent Regulatory Oversight

Regulatory bodies in the Asia-Pacific region impose strict regulations on the sale and distribution of pharmaceutical products, including laxatives. These regulations are in place to ensure consumer safety and product efficacy. Manufacturers must adhere to stringent standards and undergo rigorous testing and approvals processes. Compliance with regulatory requirements can lead to increased operational costs and limitations on marketing activities, posing a significant restraint in the market.

• Cultural and Dietary Variations across the Asia-Pacific

Cultural and dietary variations across the Asia-Pacific region require a nuanced and culturally sensitive approach to marketing laxatives. Manufacturers must consider local preferences, traditional remedies, and healthcare practices when promoting their products. Failure to navigate these cultural factors effectively can impact market acceptance and success.

This Asia-Pacific laxative market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific laxative market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In October 2021, Abbott had launched the Duphalac laxative in India. Duphalac Bears in strawberry flavor is a laxative cum food supplement and has met with the FSSAI regulations. It delivers the advantages of a trusted prebiotic and motivates the growth of good bacteria in the digestive system. The product launch would pave an important step in the children’s health improvement. It will result in increased net sales and more product range

Asia-Pacific Laxative Market Scope

The Asia-Pacific laxative market is segmented on the basis of type, flavors, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Osmotic Laxatives
• Stimulant Laxatives
• Bulk Laxatives and Lubricant
• Emollient laxatives

Flavors

• With Flavors
• Without Flavors

Source

• Natural
• Synthetic
• Others

Indication

• Chronic Constipation
• Irritable Bowel Syndrome with Constipation
• Opioid-Induced constipation
• Acute constipation
• Others

Mode of Purchase

• Prescription
• Over-the-Counter

Dosage Form

• Tablets
• Capsules
• Powder
• Liquid and Gels
• Suppositories
• Others

Route of Administration

• Oral​​​​​​​
• Rectal

Population Type

• Children
• Adults

Sales Channel

• Hospitals
• Elderly Care Centers
• Home Healthcare
• Pharmacy Stores
• Grocery/Health and Beauty Stores
• Others

Distribution Channel

• Direct Sales
• Wholesalers
• Others

Asia-Pacific Laxative Market Regional Analysis/Insights

The Asia-Pacific laxative market is analysed and market size insights and trends are provided by type, flavors, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel as referenced above.

The countries covered in the Asia-Pacific Laxative market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific (APAC).

China is leading the growth of the Asia-Pacific region and pharmaceutical/bulk drug intermediates segment is dominating in this country because China is the highest active pharmaceutical ingredient producer globally. India is the fastest growing country due to rising government initiatives for the production of APIs.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The Asia-Pacific Laxative market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific Laxative market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific Laxative market. The data is available for historic period 2015 to 2020.

Competitive Landscape and Asia-Pacific Laxative Market Share Analysis

The Asia-Pacific Laxative market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company's focus related to Asia-Pacific laxative market.

Some of the major players operating in the Asia-Pacific laxative market are:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Ireland)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• GlaxoSmithKline plc (U.K.)
• Novartis AG (Switzerland)
• Merck & Co., Inc. (U.S.)
• AstraZeneca (U.K.)
• Johnson & Johnson Private Limited (U.S.)
• Hikma Pharmaceuticals PLC (U.K.)
• Dr. Reddy's Laboratories Ltd. (India)
• Lupin (India)
• Fresenius Kabi AG (Germany)
• Aurobindo Pharma (India)
• Cipla Inc. (U.S.)
• Bausch Health Companies Inc. (Canada)
• Amneal Pharmaceuticals LLC. (U.S.)
• Apotex Inc. (Canada)
• Eli Lilly and Company (U.S.)

The Asia-Pacific laxative market is segmented on the basis of type, flavors, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Osmotic Laxatives
• Stimulant Laxatives
• Bulk Laxatives and Lubricant
• Emollient laxatives

Flavors

• With Flavors
• Without Flavors

Source

• Natural
• Synthetic
• Others

Indication

• Chronic Constipation
• Irritable Bowel Syndrome with Constipation
• Opioid-Induced constipation
• Acute constipation
• Others

Mode of Purchase

• Prescription
• Over-the-Counter

Dosage Form

• Tablets
• Capsules
• Powder
• Liquid and Gels
• Suppositories
• Others

Route of Administration

• Oral
• Rectal

Population Type

• Children
• Adults

Sales Channel

• Hospitals
• Elderly Care Centers
• Home Healthcare
• Pharmacy Stores
• Grocery/Health and Beauty Stores
• Others

Distribution Channel

• Direct Sales
• Wholesalers
• Others

Asia-Pacific Laxative Market Regional Analysis/Insights

The Asia-Pacific laxative market is analysed and market size insights and trends are provided by type, flavors, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel as referenced above.

The countries covered in the Asia-Pacific Laxative market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific (APAC).

China is leading the growth of the Asia-Pacific region and pharmaceutical/bulk drug intermediates segment is dominating in this country because China is the highest active pharmaceutical ingredient producer globally. India is the fastest growing country due to rising government initiatives for the production of APIs.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

亚太泻药市场还为您提供详细的市场分析，包括每个国家/地区资本设备医疗保健支出的增长、亚太泻药市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对亚太泻药市场的影响。数据涵盖 2015 年至 2020 年的历史时期。

竞争格局和亚太泻药市场份额分析

亚太泻药市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对亚太泻药市场的关注有关。

亚太地区泻药市场的一些主要参与者包括：

• F. Hoffmann-La Roche Ltd.（瑞士）
• Mylan NV（美国）
• Teva Pharmaceutical Industries Ltd.（爱尔兰）
• 赛诺菲（法国）
• 辉瑞公司（美国）
• 葛兰素史克公司 (英国)
• 诺华公司（瑞士）
• 默克公司（美国）
• 阿斯利康（英国）
• 强生私人有限公司（美国）
• Hikma Pharmaceuticals PLC（英国）
• Dr. Reddy's Laboratories Ltd.（印度）
• 鲁冰花（印度）
• 费森尤斯卡比公司（德国）
• Aurobindo Pharma（印度）
• Cipla Inc.（美国）
• Bausch Health Companies Inc.（加拿大）
• Amneal Pharmaceuticals LLC.（美国）
• Apotex Inc.（加拿大）
• 礼来公司 (美国)

SKU-63762